The COVID Treatment that Missed its Target

Researchers explain why those at highest risk for severe COVID-19 often least likely to get monoclonal antibodies. People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs) — a highly effective

More
4 mins read

Is 80 the new 60?

New demographic shift driven by increases in life expectancy, ‘health spa. At 81, Orlando Patterson, John Cowles Professor of Sociology, is as busy as ever. The Jamaica-born scholar of slavery and issues of race delivered a 340-page report on education reform in the

More
13 mins read
1 16 17 18 19 20 89